What is the survival rate for pancreatic cancer?
May 26, 2022
Source: Cainiu Health
Dr. Peng Xiaodong
Introduction
Pancreatic cancer has a very low survival rate. Following curative resection, the five-year survival rate does not exceed 5%. Patients with Grade IV tumors typically survive less than three months, with a typical survival period of three to six months. For those diagnosed at a locally advanced stage, median survival is approximately six to ten months. The median overall survival for patients undergoing curative resection ranges from eleven to twenty-two months, varying by individual.
Globally, the incidence of pancreatic cancer is rising, and its mortality rate remains extremely high—earning it the clinical moniker “the king of cancers.” So, what is the survival rate for pancreatic cancer?
What Is the Survival Rate for Pancreatic Cancer?
The survival rate for pancreatic cancer is very low. Following curative resection surgery, the five-year survival rate does not exceed 5%. Patients with grade IV tumors typically survive less than three months, with a typical survival period ranging from three to six months. For those diagnosed at a locally advanced stage, median survival is approximately six to ten months. Among patients undergoing curative surgical resection, the average survival duration ranges from 11 to 22 months—varying significantly by individual.
Survival rates for pancreatic cancer are closely associated with its clinical stage. For instance, in some early-stage cases—where the tumor diameter is less than 1 cm and the lesion is confined primarily to the ductal epithelium—the five-year survival rate after standard curative resection may approach 100%. However, if the tumor measures 1–2 cm in diameter and shows local invasion into lymph nodes, blood vessels, lymphatic vessels, nerves, or the pancreatic capsule, the five-year survival rate following standardized surgical resection drops to approximately 40%.
Pancreatic cancer is a highly aggressive malignancy with a notoriously poor prognosis. Upon diagnosis, patients are strongly advised to consult with specialized oncologists and tailor their treatment plan according to both their individual condition and clinical stage—thus optimizing therapeutic outcomes. We hope this response has been helpful!
